FDA Extends Comment Deadline for GE Salmon Assessments

The Food and Drug Administration (FDA) has extended until April 26, 2013,
the comment period for two draft environmental assessments of the proposed
conditions of use submitted by AquaBounty Technologies, Inc., in support of a
new animal drug application concerning a genetically engineered (GE) Atlantic
salmon and a preliminary finding of no significant impact for those specific
conditions of use.

FDA has pushed back the deadline in response to “a request for an extension to allow interested persons additional time to submit comments.” Additional details about the proposed rule appear in Issue 466 of this Update. See Federal Register, February 14, 2013.